Consequences of Different Corticosteroids on Serum Potassium and Prostate-Specific Antigen in Patients Receiving Abiraterone for Castration-Resistant Prostate Cancer: A Retrospective Observational Study

BACKGROUND: Abiraterone acetate is an androgen synthesis inhibitor approved for the treatment of castration-resistant prostate cancer (CRPC). Although co-administration of either prednisone or prednisolone at 10 mg/d has been recommended to reduce the risk of abiraterone-induced hyperaldosteronism (...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsuzawa, Masaomi, Ogawa, Ryuichi, Kinjo, Naoki, Kim, Soan, Shimizu, Fumitaka, Sakamoto, Yoshiro, Shimojima, Kazuyo, Echizen, Hirotoshi, Miyazaki, Akihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666518/
https://www.ncbi.nlm.nih.gov/pubmed/29118587
http://dx.doi.org/10.1177/1179554917737736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666518/
https://www.ncbi.nlm.nih.gov/pubmed/29118587
http://dx.doi.org/10.1177/1179554917737736

Ejemplares similares